Literature DB >> 10787080

Natural course of adrenal incidentalomas: seven-year follow-up study.

J Sirén1, P Tervahartiala, A Sivula, R Haapiainen.   

Abstract

Most adrenal incidentalomas are nonfunctioning cortical adenomas that do not require surgery. Operative treatment is indicated if the incidentaloma has malignant features as seen during the radiologic workup, is hormonally active, or grows during follow-up. A conservative attitude is justified in asymptomatic patients if we know that the natural course of these tumors is not disadvantageous. We followed a group of patients treated by observation to determine the natural course of adrenal incidentalomas. Altogether 30 incidentalomas in 27 patients were detected in the Helsinki University Central Hospital from June 1981 through December 1992 and were re-examined during 1997. The patients were evaluated clinically, and hormonal testing was done by performing a 1-mg overnight dexamethasone suppression test; the next day we measured the 24-hour urinary excretion of vanillylmandelic acid, metanephrines and normetanephrines, and serum potassium. Magnetic resonance imaging (MRI) was used to determine the size of the tumor. If the patient had died during the follow-up period, the causes of death from the death certificates and autopsy reports were reviewed. The mean follow-up was 7 years. Nine patients had died, with none of deaths related to the incidentaloma. Sixteen patients were evaluated clinically and by the basic hormonal tests and MRI; none showed any signs of hormonal activity or features of malignancy. Two patients did not want to be reexamined but stated that they were asymptomatic. This follow-up study supports the conclusion that conservative therapy is justified because the growth tendency of adrenal incidentalomas is slow and they seem to remain hormonally inactive.

Entities:  

Mesh:

Year:  2000        PMID: 10787080     DOI: 10.1007/s002689910095

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Correlation between radiologic and pathologic dimensions of adrenal masses.

Authors:  Rafael Fajardo; Jorge Montalvo; David Velázquez; Jorge Arch; Paulina Bezaury; Rosa Gamino; Miguel F Herrera
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

2.  Role for catecholamines in tumor progression: possible use for β-blockers in the treatment of cancer.

Authors:  Eric V Yang
Journal:  Cancer Biol Ther       Date:  2010-07-06       Impact factor: 4.742

3.  Management of adrenal incidentaloma by laparoscopic transperitoneal anterior and submesocolic approach.

Authors:  Alessandro M Paganini; Mario Guerrieri; Andrea Balla; Silvia Quaresima; Andrea M Isidori; Franco Iafrate; Giancarlo D'Ambrosio; Giovanni Lezoche; Emanuele Lezoche
Journal:  Langenbecks Arch Surg       Date:  2015-12-18       Impact factor: 3.445

4.  Flank approach versus anterior sub-mesocolic access in left laparoscopic adrenalectomy: a prospective randomized study.

Authors:  E Lezoche; M Guerrieri; F Crosta; G Lezoche; M Baldarelli; R Campagnacci
Journal:  Surg Endosc       Date:  2008-02-21       Impact factor: 4.584

5.  Disappearing adrenal masses.

Authors:  I G Hermsen; M P J Polak; H R Haak
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

6.  Guidelines for the management of the incidentally discovered adrenal mass.

Authors:  Anil Kapoor; Topher Morris; Ryan Rebello
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

Review 7.  Subclinical Cushing's syndrome.

Authors:  Massimo Terzolo; Giuseppe Reimondo; Silvia Bovio; Alberto Angeli
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

8.  Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery.

Authors:  Yeşim Erbil; Evin Ademoğlu; Neşe Ozbey; Umut Barbaros; Burcu Tulumoğlu Yanik; Artur Salmaslioğlu; Alp Bozbora; Selçuk Ozarmağan
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

9.  Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas.

Authors:  H Yilmaz; N B Tütüncü; M Sahin
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

10.  Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas.

Authors:  S Yener; S Ertilav; M Secil; T Demir; B Akinci; L Kebapcilar; A Comlekci; F Bayraktar; S Yesil
Journal:  J Endocrinol Invest       Date:  2009-06-18       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.